EFFICACY AND SAFETY OF FIXED-DOSE COMBINATION OF ROSUVASTATIN AND IRBESARTAN IN PATIENTS WITH DYSLIPIDEMIA AND HYPERTENSION
ATHEROSCLEROSIS（2014）
Abstract
Objectives: Hypertension and dyslipidemia are important major risk factors of cardiovascular disease. These are components of metabolic syndrome and are usually co-morbid and not so easy to achieve treatment goals with non-pharmaocological and pharmacological therapy.
MoreTranslated text
Key words
rosuvastatin,dyslipidemia,irbesartan,hypertension,fixed-dose
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined